Walmart’s various forays into the healthcare space have fallen short of economic viability over a number of years. As such, it may be surprising that healthcare researchers and business schools haven’t devoted more attention to assessing why that is, or why the company continues to expend capital without much of a return to show. Finally, the University of Pennsylvania’s Wharton School of Business has taken a stab at it in an article published in the …
Read More









